Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
American Society for Cell Biology Annual Meeting
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.
Remyelination therapy goes to trial for multiple sclerosis
Motor skill learning requires active central myelination.
Drak2 Does Not Regulate TGF-β Signaling in T Cells.
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
Vitamin D intake and incidence of multiple sclerosis.
[Intractable vomiting as first manifestation of neuromyelitis Optica.]
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
Increase in mRNA Level of Orexin1 and 2 Receptors Following Induction of Experimental Autoimmune Encephalomyelitis in Mice.
Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination.
Differential effects of fingolimod on B-cell populations in multiple sclerosis.
Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.
The risk of varicella zoster virus infection in multiple sclerosis patients treated with fingolimod.
Microglia activation is associated with IFN-α induced depressive-like behavior.
GEMSP: A New Therapeutic Approach to Multiple Sclerosis.
Combination Treatment of Interferon β-1b and Warfarin for a Patient With Baló's Concentric Sclerosis and Antiphospholipid Syndrome.
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord.
Epidemiology of Neuromyelitis Optica in the United States: A Multicenter AnalysisEpidemiology of NMO.

Pages